×
About 4,875 results

ALLMedicine™ Ductal Carcinoma In Situ Center

Research & Reviews  1,661 results

Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Br...
https://doi.org/10.1001/jamanetworkopen.2022.10331
JAMA Network Open; Fazeli S, Snyder BS et. al.

May 11th, 2022 - Guiding treatment decisions for women with ductal carcinoma in situ (DCIS) requires understanding patient preferences and the influence of preoperative magnetic resonance imaging (MRI) and surgeon recommendation. To identify factors associated wit...

Uninformed breast cancer patients are making treatment decisions
https://www.mdedge.com/hematology-oncology/article/254508/metastatic-breast-cancer/uninformed-breast-cancer-patients-are
Diana Kwon

May 10th, 2022 - Women with ductal carcinoma in situ (DCIS) breast cancer are generally uninformed about their diagnosis and are making uninformed treatment decisions, according to results of a study presented this month at ESMO Breast Cancer 2022, an annual meeti.

Breast Cancer Histology
http://emedicine.medscape.com/article/1954658-overview

May 10th, 2022 - Overview Breast cancers usually are epithelial tumors of ductal or lobular origin. Breast cancers are classified as follows: Ductal carcinoma in situ (DCIS) Lobular carcinoma in situ Invasive ductal carcinoma (ductal breast cancer) Invasive lobula...

Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
https://clinicaltrials.gov/ct2/show/NCT01872975

May 9th, 2022 - PRIMARY OBJECTIVES: To evaluate whether the addition of chest wall + regional nodal radiation therapy (XRT) after mastectomy or breast + regional nodal XRT after breast conserving surgery will significantly reduce the rate of events for invasive b...

see more →

Guidelines  2 results

Updated recommendations regarding the management of older patients with breast cancer: ...
https://doi.org/10.1016/S1470-2045(20)30741-5
The Lancet. Oncology; Biganzoli L, Battisti NML et. al.

May 18th, 2021 - Breast cancer is increasingly prevalent in older adults and is a substantial part of routine oncology practice. However, management of breast cancer in this population is challenging because the disease is highly heterogeneous and there is insuffi...

Society of Surgical Oncology-American Society for Radiation Oncology-American Society o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047939
Annals of Surgical Oncology; Morrow M, Van Zee KJ et. al.

Aug 17th, 2016 - Controversy exists regarding the optimal negative margin width for ductal carcinoma in situ (DCIS) treated with breast-conserving surgery and whole-breast irradiation. A multidisciplinary consensus panel used a meta-analysis of margin width and ip...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  51 results

Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
https://clinicaltrials.gov/ct2/show/NCT01872975

May 9th, 2022 - PRIMARY OBJECTIVES: To evaluate whether the addition of chest wall + regional nodal radiation therapy (XRT) after mastectomy or breast + regional nodal XRT after breast conserving surgery will significantly reduce the rate of events for invasive b...

Metformin and Nightly Fasting in Women With Early Breast Cancer
https://clinicaltrials.gov/ct2/show/NCT05023967

Apr 15th, 2022 - PRIMARY OBJECTIVES: I. To assess the safety of the experimental intervention based on the frequency of occurrence of a dose limiting toxicity (DLT) in the first 14 participants assigned to the experimental treatment arm. II. Evaluate the differenc...

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
https://clinicaltrials.gov/ct2/show/NCT01547741

Apr 14th, 2022 - OBJECTIVES: Primary To determine if the docetaxel and cyclophosphamide (TC) regimen is non-inferior to the anthracycline-based chemotherapy regimens in terms of invasive disease-free survival (DFS) by combining B-49 data with the docetaxel, doxoru...

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
https://clinicaltrials.gov/ct2/show/NCT04797299

Apr 5th, 2022 - A prospective cohort study, conducted in Canada, to prospectively evaluate whether the combination of clinicopathological criteria and the Oncotype DX DCIS score can identify a group of women at very low risk of local recurrence following breast c...

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
https://clinicaltrials.gov/ct2/show/NCT01275677

Mar 22nd, 2022 - PRIMARY OBJECTIVES: I. To determine whether the addition of trastuzumab to chemotherapy (TC or AC→WP) improves invasive disease-free survival (IDFS) in women with resected node-positive or high-risk node-negative breast cancer which is reported as...

see more →

News  229 results

Uninformed Breast Cancer Patients Are Making Treatment Decisions
https://www.medscape.com/viewarticle/973783

May 11th, 2022 - Women with ductal carcinoma in situ (DCIS) breast cancer are generally uninformed about their diagnosis and are making uninformed treatment decisions, according to results of a study presented this month at ESMO Breast Cancer 2022, an annual meeti...

Uninformed breast cancer patients are making treatment decisions
https://www.mdedge.com/hematology-oncology/article/254508/metastatic-breast-cancer/uninformed-breast-cancer-patients-are
Diana Kwon

May 10th, 2022 - Women with ductal carcinoma in situ (DCIS) breast cancer are generally uninformed about their diagnosis and are making uninformed treatment decisions, according to results of a study presented this month at ESMO Breast Cancer 2022, an annual meeti.

Recurrent DCIS Can Be Genetically Distinct From Primary Lesion
https://www.medscape.com/viewarticle/971905

Apr 11th, 2022 - UPDATED April 12, 2022 // Editor's note: This article has been updated with comments. NEW ORLEANS ― In more than 10% of cases in which ductal carcinoma in situ (DCIS) recurs in the same breast, the new lesion is genetically distinct from the origi...

ASCO/CAP Issue New Guidelines for IHC Hormone Testing in Breast Cancer
https://www.onclive.com/view/ihc_hormone_testing

Mar 15th, 2022 - The American Society of Clinical Oncology (ASCO) and the College of American Pathologists (CAP) jointly released guidelines designed to improve the accuracy and usefulness of immunohistochemical (IHC) testing for estrogen receptor (ER) and progest...

DCIS and Low-Risk, Early-Stage Breast Cancer
https://www.medscape.com/viewarticle/963165

Mar 15th, 2022 - This transcript has been edited for clarity. Lidia Schapira, MD: Hello. I'm Lidia Schapira, and I'm your host for this program, Medscape InDiscussion: Breast Cancer. Before I introduce this episode's guest, I wanted to begin with a case study that...

see more →

Patient Education  2 results see all →